174 related articles for article (PubMed ID: 33361738)
21. Prevalence by age and predictors of medullary thyroid cancer in patients with lower risk germline RET proto-oncogene mutations.
Rich TA; Feng L; Busaidy N; Cote GJ; Gagel RF; Hu M; Jimenez C; Lee JE; Perrier N; Sherman SI; Waguespack SG; Ying A; Grubbs E
Thyroid; 2014 Jul; 24(7):1096-106. PubMed ID: 24617864
[TBL] [Abstract][Full Text] [Related]
22. Late-onset medullary carcinoma of the thyroid: need for genetic testing and prophylactic thyroidectomy in adult family members.
Shaha AR; Cohen T; Ghossein R; Tuttle RM
Laryngoscope; 2006 Sep; 116(9):1704-7. PubMed ID: 16955009
[TBL] [Abstract][Full Text] [Related]
23. Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation.
Jasim S; Ying AK; Waguespack SG; Rich TA; Grubbs EG; Jimenez C; Hu MI; Cote G; Habra MA
Thyroid; 2011 Feb; 21(2):189-92. PubMed ID: 21186952
[TBL] [Abstract][Full Text] [Related]
24. When is prophylactic thyroidectomy indicated for patients with the RET codon 609 mutation?
Calva D; O'Dorisio TM; Sue O'Dorisio M; Lal G; Sugg S; Weigel RJ; Howe JR
Ann Surg Oncol; 2009 Aug; 16(8):2237-44. PubMed ID: 19472011
[TBL] [Abstract][Full Text] [Related]
25. Single nucleotide polymorphisms act as modifiers and correlate with the development of medullary and simultaneous medullary/papillary thyroid carcinomas in 2 large, non-related families with the RET V804M proto-oncogene mutation.
Shifrin AL; Ogilvie JB; Stang MT; Fay AM; Kuo YH; Matulewicz T; Xenachis CZ; Vernick JJ
Surgery; 2010 Dec; 148(6):1274-80; discussion 1280-1. PubMed ID: 21134561
[TBL] [Abstract][Full Text] [Related]
26. Risk Profile of the RET A883F Germline Mutation: An International Collaborative Study.
Mathiesen JS; Habra MA; Bassett JHD; Choudhury SM; Balasubramanian SP; Howlett TA; Robinson BG; Gimenez-Roqueplo AP; Castinetti F; Vestergaard P; Frank-Raue K
J Clin Endocrinol Metab; 2017 Jun; 102(6):2069-2074. PubMed ID: 28323957
[TBL] [Abstract][Full Text] [Related]
27. Do the recent American Thyroid Association (ATA) Guidelines accurately guide the timing of prophylactic thyroidectomy in MEN2A?
Grubbs EG; Waguespack SG; Rich TA; Xing Y; Ying AK; Evans DB; Lee JE; Perrier ND
Surgery; 2010 Dec; 148(6):1302-9; discussion 1309-10. PubMed ID: 21134565
[TBL] [Abstract][Full Text] [Related]
28. RET proto oncogene mutation detection and medullary thyroid carcinoma prevention.
Yeganeh MZ; Sheikholeslami S; Hedayati M
Asian Pac J Cancer Prev; 2015; 16(6):2107-17. PubMed ID: 25824727
[TBL] [Abstract][Full Text] [Related]
29. Hereditary medullary thyroid carcinoma: the management dilemma.
Zhou P; Liu J; Cheng SW; Wang B; Yang R; Peng L
Fam Cancer; 2012 Jun; 11(2):157-65. PubMed ID: 22183190
[TBL] [Abstract][Full Text] [Related]
30. Surgical strategy in a kindred with a rare RET protooncogene mutation of variable penetrance with regard to multiple endocrine neoplasia.
Colombo-Benkmann M; Brämswig J; Höppner W; Gellner R; Hengst K; Böcker W; Senninger N
World J Surg; 2002 Oct; 26(10):1286-90. PubMed ID: 12205548
[TBL] [Abstract][Full Text] [Related]
31. The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 years experience at one single center.
Elisei R; Romei C; Renzini G; Bottici V; Cosci B; Molinaro E; Agate L; Cappagli V; Miccoli P; Berti P; Faviana P; Ugolini C; Basolo F; Vitti P; Pinchera A
J Clin Endocrinol Metab; 2012 Feb; 97(2):426-35. PubMed ID: 22162466
[TBL] [Abstract][Full Text] [Related]
32. Multiple Endocrine Neoplasia Type 2B Associated Mixed Medullary and Follicular Thyroid Carcinoma in A Chinese Patient with RET M918T Germline Mutation.
Qi XP; Lin GB; Chen B; Li F; Cao ZL; Zheng WH; Zhao JQ
Endocr Metab Immune Disord Drug Targets; 2021; 21(3):554-560. PubMed ID: 32660411
[TBL] [Abstract][Full Text] [Related]
33. Germline RET sequence variation I852M and occult medullary thyroid cancer: harmless polymorphism or causative mutation?
Machens A; Spitschak A; Lorenz K; Pützer BM; Dralle H
Clin Endocrinol (Oxf); 2011 Dec; 75(6):801-5. PubMed ID: 21711375
[TBL] [Abstract][Full Text] [Related]
34. New presentation of familial medullary thyroid carcinoma in 87-year-old patient with high-risk RET proto-oncogene codon 620 mutation.
Jaggard MK; MacRae C; Ifeacho S; Robinson S; Tolley NS
J Laryngol Otol; 2009 Jul; 123(7):796-800. PubMed ID: 18771606
[TBL] [Abstract][Full Text] [Related]
35. The RET mutation E768D confers a late-onset familial medullary thyroid carcinoma -- only phenotype with incomplete penetrance: implications for screening and management of carrier status.
Dabir T; Hunter SJ; Russell CF; McCall D; Morrison PJ
Fam Cancer; 2006; 5(2):201-4. PubMed ID: 16736292
[TBL] [Abstract][Full Text] [Related]
36. Occurrence of medullary thyroid carcinoma, bronchial carcinoid tumor, and papillary thyroid carcinoma in a family bearing the RET G691S polymorphism.
Rotondi M; Ercolino T; Fonte R; Lagonigro MS; Leporati P; Villani L; La Manna L; Mannelli M; Chiovato L
J Endocrinol Invest; 2009 Feb; 32(2):115-8. PubMed ID: 19411807
[TBL] [Abstract][Full Text] [Related]
37. RET gene mutation analysis and long-term clinical outcomes of medullary thyroid cancer patients.
Prabhu M; Shakya S; Ballal S; Ahmed Shamim S; Bal C
Nucl Med Commun; 2020 Nov; 41(11):1136-1142. PubMed ID: 32796450
[TBL] [Abstract][Full Text] [Related]
38. A novel germline variant in RET gene resulting in an additional cysteine in a family with familial medullary thyroid carcinoma.
Oriola J; Sanchez A; Paniello B; de la Bellacasa JP; Biarnés J
Fam Cancer; 2021 Jul; 20(3):253-256. PubMed ID: 33084974
[TBL] [Abstract][Full Text] [Related]
39. Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2.
Moore SW; Appfelstaedt J; Zaahl MG
J Pediatr Surg; 2007 Feb; 42(2):326-32. PubMed ID: 17270543
[TBL] [Abstract][Full Text] [Related]
40. [Prophylactic thyroidectomy in RET proto-oncogen mutation].
Rodríguez Caraballo L; Gómez-Chacón Villalba J; Rodríguez Iglesias P; Cortés Sáez J; Moreno Macián F; Marco Macián A; Vila Carbó JJ
Cir Pediatr; 2017 Apr; 30(2):100-104. PubMed ID: 28857533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
